瘦素对大鼠肝纤维化的信号转导调控及槲寄生碱的干预作用
[Abstract]:Objective To study the signal transduction mechanism and the intervention effect of leptin in the control of hepatic fibrosis in rats. Methods The model of hepatic fibrosis induced by CCl4 was studied. Forty-five rats were randomly divided into three groups: control group, model group and drug intervention group. The control group did not do any treatment, the free diet, the drinking water, the model group and the mistletoe treatment group were respectively injected with 40% CCl4-vegetable oil solution 2 ml/ kg, twice a week for 8 weeks. In the 9th week of the experiment, the treated group was given a total of 8g/ (kg 路 d) of mistletoe in rats, and the model group was given an equal dose of normal saline for 8 weeks. All animals were sacrificed at the 17-week cervical dislocation, and the left anterior lobe of the liver was removed. The effect of mistletoe on the morphology of hepatic fibrosis in rats with hepatic fibrosis was observed by HE staining and MASSON staining. The effect of mistletoe on the leptin and leptin receptor in rat hepatic stellate cells was observed by immunohistochemistry. The levels of JAK2, STAT3 protein and JAK2 and STAT3 protein were detected by Western Blot method. Results The results suggested that the liver fibrosis model of the rat was successful, and the mistletoe had the effect of blocking and reversing the hepatic fibrosis. Immunohistochemistry staining showed that the mistletoe significantly inhibited the expression of leptin and leptin receptor in the model rats compared with the model group. Western Blot showed that the expression of JAK2 and STAT3 in the normal control group was the least; the expression of JAK2 and STAT3 in the model group was significantly lower; and the expression of JAK2 and STAT3 in the drug-treated group was significantly reduced. Conclusion The mistletoe can effectively reverse the rat liver fibrosis, and the mechanism of action may be accomplished by down-regulating the expression of leptin and leptin receptor in rat liver tissue, and further affecting the signal pathway of JAK2/ STAT3.
【作者单位】: 首都医科大学实验动物部;首都医科大学病理生理教研室;
【基金】:国家自然科学基金资助项目(81272757) 北京市属高等学校创新团队建设与教师职业发展计划项目(IDHT20150502)
【分类号】:R575.2
【参考文献】
相关期刊论文 前4条
1 高连印,车念聪,付修文,钱英;槲芪散治疗慢性乙型病毒性肝炎30例疗效分析[J];北京中医;2001年03期
2 王学江,钱英,丰平,文朝阳,姜大巍;槲芪散对肝癌前病变血清同功酶影响的研究[J];北京中医药大学学报;2000年S1期
3 文朝阳;史争鸣;李霞;丰平;刘树红;王学江;;槲寄生总碱和多糖对黄曲霉菌毒素诱发大鼠肝癌前病变时血清同工酶含量的影响[J];中国药理学与毒理学杂志;2009年03期
4 陈柏年,杨官娥,漆小梅,李青山;槲寄生抗肿瘤有效成分研究进展[J];中国新药杂志;2005年10期
【共引文献】
相关期刊论文 前10条
1 张秋云;丁相海;刘绍能;章红英;钱英;黄娟;高连印;付修文;杜宇琼;谭勇;;调肝颗粒剂对CCl_4慢性肝损伤大鼠肝功能及肝组织保护作用的实验研究[J];北京中医药;2008年06期
2 丰平;徐大鹏;刘树红;李向利;文朝阳;;调肝颗粒剂防治大鼠肝癌前病变的病理研究[J];北京中医药;2010年08期
3 孔凡青;周立社;闫巧梅;高丽君;闫秀英;;槲寄生碱对人肝癌细胞SMMC-7721生长抑制作用的研究[J];包头医学院学报;2007年04期
4 宋洪杰;曹丽君;;海利升注射液辅助治疗癌症患者9例临床疗效观察[J];当代医学;2010年01期
5 孙长岗;刘瑞娟;孟肖路;;海利升注射液联合化疗治疗中晚期NSCLC疗效观察[J];当代医学;2010年06期
6 曹源;胡晓松;;PDGF介导的信号通路在肝纤维化肝星状细胞活化增殖过程中的作用[J];重庆医学;2013年33期
7 朱云;程e,
本文编号:2347241
本文链接:https://www.wllwen.com/yixuelunwen/xiaohjib/2347241.html